BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 25936357)

  • 1. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
    Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
    Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells.
    An J; Ha EM
    J Microbiol Biotechnol; 2016 Aug; 26(8):1490-503. PubMed ID: 27221111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
    Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.
    Dallas NA; Xia L; Fan F; Gray MJ; Gaur P; van Buren G; Samuel S; Kim MP; Lim SJ; Ellis LM
    Cancer Res; 2009 Mar; 69(5):1951-7. PubMed ID: 19244128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
    Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
    Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
    J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
    Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
    Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
    Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC
    J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
    Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.